Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM)
USD 26.6
(-1.23%)
USD 26.6
(-1.23%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 130.19 Million USD | 46.95% |
| 2022 | 88.59 Million USD | 22.24% |
| 2021 | 72.47 Million USD | 48.3% |
| 2020 | 48.87 Million USD | -4.48% |
| 2019 | 51.16 Million USD | 23.67% |
| 2018 | 41.37 Million USD | 54.52% |
| 2017 | 26.77 Million USD | 34.26% |
| 2016 | 19.94 Million USD | 105.25% |
| 2015 | 9.71 Million USD | 485.3% |
| 2014 | 1.66 Million USD | 16500.0% |
| 2013 | 10 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 34.58 Million USD | -4.86% |
| 2024 Q2 | 48.93 Million USD | 41.5% |
| 2023 Q2 | 33.47 Million USD | 28.22% |
| 2023 Q3 | 34.26 Million USD | 2.38% |
| 2023 FY | 130.19 Million USD | 46.95% |
| 2023 Q4 | 36.35 Million USD | 6.1% |
| 2023 Q1 | 26.1 Million USD | 28.4% |
| 2022 Q3 | 22.82 Million USD | -2.14% |
| 2022 Q1 | 22.12 Million USD | 9.57% |
| 2022 Q4 | 20.32 Million USD | -10.93% |
| 2022 FY | 88.59 Million USD | 22.24% |
| 2022 Q2 | 23.32 Million USD | 5.44% |
| 2021 Q4 | 20.18 Million USD | 7.89% |
| 2021 Q2 | 18.13 Million USD | 17.43% |
| 2021 FY | 72.47 Million USD | 48.3% |
| 2021 Q1 | 15.44 Million USD | 5.81% |
| 2021 Q3 | 18.71 Million USD | 3.18% |
| 2020 Q2 | 8.06 Million USD | -31.79% |
| 2020 Q4 | 14.59 Million USD | 1.36% |
| 2020 FY | 48.87 Million USD | -4.48% |
| 2020 Q1 | 11.81 Million USD | -6.24% |
| 2020 Q3 | 14.39 Million USD | 78.65% |
| 2019 Q3 | 12.75 Million USD | -5.63% |
| 2019 Q4 | 12.6 Million USD | -1.18% |
| 2019 Q1 | 12.29 Million USD | 7.96% |
| 2019 Q2 | 13.51 Million USD | 9.98% |
| 2019 FY | 51.16 Million USD | 23.67% |
| 2018 Q1 | 8.86 Million USD | 20.83% |
| 2018 Q4 | 11.38 Million USD | 6.01% |
| 2018 FY | 41.37 Million USD | 54.52% |
| 2018 Q2 | 10.38 Million USD | 17.13% |
| 2018 Q3 | 10.73 Million USD | 3.42% |
| 2017 Q3 | 6.48 Million USD | -5.45% |
| 2017 Q2 | 6.85 Million USD | 12.47% |
| 2017 Q1 | 6.09 Million USD | 5.25% |
| 2017 FY | 26.77 Million USD | 34.26% |
| 2017 Q4 | 7.33 Million USD | 13.17% |
| 2016 Q2 | 4.9 Million USD | 12.01% |
| 2016 FY | 19.94 Million USD | 105.25% |
| 2016 Q1 | 4.38 Million USD | 25.06% |
| 2016 Q4 | 5.79 Million USD | 19.17% |
| 2016 Q3 | 4.86 Million USD | -0.94% |
| 2015 Q2 | 1.96 Million USD | 25.85% |
| 2015 Q1 | 1.56 Million USD | 184.18% |
| 2015 Q4 | 3.5 Million USD | 30.56% |
| 2015 FY | 9.71 Million USD | 485.3% |
| 2015 Q3 | 2.68 Million USD | 36.4% |
| 2014 Q4 | 550 Thousand USD | 24.72% |
| 2014 Q1 | 2000.00 USD | -20.0% |
| 2014 FY | 1.66 Million USD | 16500.0% |
| 2014 Q2 | 667 Thousand USD | 33250.0% |
| 2014 Q3 | 441 Thousand USD | -33.88% |
| 2013 Q3 | 2500.00 USD | 0.0% |
| 2013 Q1 | 2500.00 USD | 0.0% |
| 2013 Q2 | 2500.00 USD | 0.0% |
| 2013 Q4 | 2500.00 USD | 0.0% |
| 2013 FY | 10 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | - USD | -Infinity% |
| BIMI International Medical Inc. | 11.83 Million USD | -1000.497% |
| China Jo-Jo Drugstores, Inc. | 154.54 Million USD | 15.755% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 130.19 Million USD | 0.0% |
| Leafly Holdings, Inc. | 42.25 Million USD | -208.135% |
| Leafly Holdings, Inc. | 42.25 Million USD | -208.135% |
| LifeMD, Inc. | 152.54 Million USD | 14.654% |
| LifeMD, Inc. | 152.54 Million USD | 14.654% |
| TRxADE HEALTH, Inc. | 8.27 Million USD | -1473.859% |
| PetMed Express, Inc. | 281.06 Million USD | 53.679% |
| Walgreens Boots Alliance, Inc. | 147.65 Billion USD | 99.912% |